165 related articles for article (PubMed ID: 11237072)
1. Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation.
Li Z; Deeg HJ
Leukemia; 2001 Mar; 15(3):465-7. PubMed ID: 11237072
[TBL] [Abstract][Full Text] [Related]
2. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy and hemopoietic stem cell transplantation for myelofibrosis.
Li Z; Gooley T; Applebaum FR; Deeg HJ
Blood; 2001 Apr; 97(7):2180-1. PubMed ID: 11286221
[No Abstract] [Full Text] [Related]
4. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation.
Robin M; Zine M; Chevret S; Meignin V; Munoz-Bongrand N; Moatti H; Xhaard A; Sicre de Fontbrune F; Peffault de Latour R; Sarfati E; Socié G
Biol Blood Marrow Transplant; 2017 Jun; 23(6):958-964. PubMed ID: 28263921
[TBL] [Abstract][Full Text] [Related]
6. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
7. Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
Hart C; Klatt S; Barop J; Müller G; Schelker R; Holler E; Huber E; Herr W; Grassinger J
Haematologica; 2016 Nov; 101(11):1407-1416. PubMed ID: 27662011
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy for agnogenic myeloid metaplasia.
Coon WW; Liepman MK
Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Barosi G; Bacigalupo A
Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
[TBL] [Abstract][Full Text] [Related]
12. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
DiBella NJ; Silverstein MN; Hoagland HC
Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
Malato A; Rossi E; Tiribelli M; Mendicino F; Pugliese N
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):588-595. PubMed ID: 32482540
[TBL] [Abstract][Full Text] [Related]
14. 'Early' splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940.
Benbassat J; Penchas S
Acta Haematol; 1981; 65(3):189-92. PubMed ID: 6785973
[TBL] [Abstract][Full Text] [Related]
15. Transplant decision-making strategies in the myeloproliferative disorders.
Fruchtman SM
Semin Hematol; 2003 Jan; 40(1 Suppl 1):30-3. PubMed ID: 12682880
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].
Sakashita C; Akiyama H; Mori S; Ohashi K; Sakamaki H
Rinsho Ketsueki; 2000 Mar; 41(3):206-11. PubMed ID: 10774249
[TBL] [Abstract][Full Text] [Related]
18. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
Benbassat J; Gilon D; Penchas S
Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy before allogeneic hematopoietic stem-cell transplantation for myelofibrosis: Tumor burden matters!
Ho VT; Rambaldi A
Am J Hematol; 2021 Jan; 96(1):12-13. PubMed ID: 33219701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
